List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 179 studies with search of: Open Studies | "Multiple Sclerosis"
Include studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Not yet recruiting Autologous Mesenchymal Stem Cell (MSC) Transplantation in MS
Conditions: Relapsing-Remitting Multiple Sclerosis;   Secondary Progressive Multiple Sclerosis;   Progressive Relapsing Multiple Sclerosis
Intervention: Biological: Autologous mesenchymal stem cell transplantation
2 Recruiting Patient Research Cohort: Rapidly Evolving Multiple Sclerosis
Conditions: Relapsing-Remitting Multiple Sclerosis;   Secondary Progressive Multiple Sclerosis
Intervention:
3 Recruiting Evaluation of Efficiency of Ritalin in Multiple Sclerosis (MS) Patients
Conditions: Relapsing Remitting Multiple Sclerosis;   Multiple Sclerosis, Chronic Progressive
Intervention: Drug: Ritalin
4 Recruiting Safety/Effectiveness of Adding Monthly Dexamethasone to Weekly Avonex for MS
Conditions: Relapsing-Remitting Multiple Sclerosis,;   Mono-Symptomatic Multiple Sclerosis
Intervention:
5 Recruiting Double Blind Placebo-Controlled Phase I/II Clinical Trial of Idebenone in Patients With Primary Progressive Multiple Sclerosis (IPPoMS)
Condition: Primary Progressive Multiple Sclerosis
Intervention: Drug: Idebenone
6 Not yet recruiting Safety and Immunologic Effect of Low Dose Versus High Dose Vitamin D3 in Relapsing Remitting Multiple Sclerosis
Conditions: Multiple Sclerosis;   Vitamin D Deficiency
Intervention: Dietary Supplement: Cholecalciferol
7 Recruiting Effect of Multiple Infusions of AIN457 on Disease Activity in Relapsing-remitting Multiple Sclerosis
Conditions: Multiple Sclerosis;   Relapsing-Remitting
Interventions: Drug: AIN457;   Drug: Placebo
8 Recruiting A Safety Study of Combination Treatment With Avonex and Placebo-Controlled Dosing of Topamax in Relapsing-Remitting Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Drug: Avonex and Topamax
9 Recruiting Effect of Adrenocorticotropin Injection With Weekly Interferon Beta in Patients With Relapsing Remitting Multiple Sclerosis (MS)
Condition: Multiple Sclerosis
Interventions: Drug: repository corticotropin injection;   Drug: Saline
10 Recruiting A Study of Patients With Relapsing Remitting Multiple Sclerosis
Condition: Relapsing-Remitting Multiple Sclerosis
Interventions: Drug: LY2127399;   Drug: Placebo
11 Recruiting Gene Expression Profiles in Multiple Sclerosis (MS)
Condition: Multiple Sclerosis
Intervention: Procedure: Blood Draw
12 Recruiting Investigation of Simvastatin in Secondary Progressive Multiple Sclerosis
Condition: Secondary Progressive Multiple Sclerosis
Interventions: Drug: Simvastatin;   Drug: Placebo
13 Recruiting Modeling and Treating the Pathophysiology of Demyelination in Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Drug: ACTHAR
14 Recruiting Sunphenon in Progressive Forms of Multiple Sclerosis
Condition: Primary or Secondary Chronic-Progressive Multiple Sclerosis
Interventions: Drug: Sunphenon EGCG;   Drug: Placebo
15 Recruiting The Neuroprotective Effect of Lamotrigine and Interferon Beta 1a in Patients With Relapsing-Remitting Multiple Sclerosis
Condition: Relapsing-Remitting Multiple Sclerosis
Intervention: Drug: lamotrigine
16 Recruiting Study Of SB-683699 Compared To Placebo In Subjects With Relapsing-Remitting Multiple Sclerosis (MS)
Condition: Relapsing Remitting Multiple Sclerosis
Intervention: Drug: SB-683699
17 Recruiting Safety and Efficacy Study of Daclizumab HYP to Treat Relapsing-Remitting Multiple Sclerosis
Condition: Multiple Sclerosis, Relapsing-Remitting
Interventions: Drug: daclizumab HYP;   Other: placebo
18 Recruiting Magnetic Resonance Imaging to Detect Brain Damage in Patients With Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention:
19 Recruiting Sunphenon Epigallocatechin-Gallate (EGCg) in Relapsing-Remitting Multiple Sclerosis (SuniMS Study)
Condition: Relapsing-Remitting Multiple Sclerosis
Interventions: Drug: epigallocatechin-gallate (Sunphenon);   Drug: placebo
20 Recruiting Safety, Tolerability, Efficacy and Optimal Dose Finding Study of BAF312 in Patients With Relapsing-remitting Multiple Sclerosis
Condition: Relapsing-Remitting Multiple Sclerosis
Interventions: Drug: BAF312 10mg;   Drug: BAF312 2 mg;   Drug: BAF312 0.5 mg;   Drug: Placebo

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services